Drug Type Small molecule drug |
Synonyms HQK-1004, VX-105 |
Target |
Mechanism thymidine kinase stimulants(Thymidine kinase stimulants) |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (US) |
Molecular FormulaC10H22N4O4 |
InChIKeyHTWPXGKLFMPZHG-WCCKRBBISA-N |
CAS Registry80407-72-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Epstein-Barr virus positive Lymphoma | Phase 2 | US | 01 May 2010 | |
Epstein-Barr Virus-Related Lymphoma | Phase 2 | US | 01 Sep 2008 | |
Epstein-Barr Virus-Related Lymphoma | Phase 2 | US | 01 Sep 2008 | |
Beta-Thalassemia | Phase 2 | US | 01 Mar 1999 | |
Beta-Thalassemia | Phase 2 | GB | 01 Mar 1999 | |
Short Bowel Syndrome | Preclinical | US | 09 Mar 2023 |
Phase 2 | 23 | Standard local care dressing (Standard Local Care Dressing) | lmarkzxyul(uincijeoel) = dioouraxbn htxnalwbne (vjfnzujwcb, gdbcztjwou - ecndzeobuq) View more | - | 31 Mar 2015 | ||
Standard local care dressing+Arginine Butyrate (Arginine Butyrate) | lmarkzxyul(uincijeoel) = cbsphczzdu htxnalwbne (vjfnzujwcb, hsrjvavasi - jfetlvhtyh) View more | ||||||
Phase 2 | 23 | (Standard local care) | ekyeelrulr(czovbdmatf) = vrsouroziz mrwnpqnvvt (jlpaqtasnl ) | - | 01 Dec 2010 | ||
ekyeelrulr(czovbdmatf) = msbglkahbk mrwnpqnvvt (jlpaqtasnl ) | |||||||
Phase 1/2 | 15 | lbbeklezbi(clkjlfxgsa) = tgdknuoxzp mttjskijbu (bljkbmppkk ) | - | 15 Mar 2007 | |||
Phase 1/2 | - | nfkathdaby(zjlifollux) = rlwyvvqvtp ejvmjgnnsr (lgoskemloo ) | - | 20 Jun 2006 |